BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19793162)

  • 1. Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.
    Hernandez RK; Farwell W; Cantor MD; Lawler EV
    J Am Geriatr Soc; 2009 Nov; 57(11):1997-2003. PubMed ID: 19793162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
    Prescrire Int; 2011 Apr; 20(115):95. PubMed ID: 21648211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.
    Inglis F
    Int J Clin Pract Suppl; 2002 Jun; (127):45-63. PubMed ID: 12139367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Featured CME topic: dementia. Medication update.
    Slagle MA
    South Med J; 2001 Jul; 94(7):678-81. PubMed ID: 11531174
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-Alzheimer drugs: life-threatening adverse effects.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do we treat people with dementia in Croatia.
    Mimica N; Presecki P
    Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterase inhibitors in the treatment of dementia.
    Ellis JM
    J Am Osteopath Assoc; 2005 Mar; 105(3):145-58. PubMed ID: 15863734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.
    Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
    Rodda J; Morgan S; Walker Z
    Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of pneumonia in new users of cholinesterase inhibitors for dementia.
    Lai EC; Wong MB; Iwata I; Zhang Y; Hsieh CY; Kao Yang YH; Setoguchi S
    J Am Geriatr Soc; 2015 May; 63(5):869-76. PubMed ID: 25912671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
    Kaufer DI
    Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():32-9. PubMed ID: 14676467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinesterase duration in the Australian veteran population.
    Gadzhanova S; Roughead L; Mackson J
    Aust N Z J Psychiatry; 2010 May; 44(5):469-74. PubMed ID: 20397790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cardiovascular safety of dementia medications: a cross-national study.
    Fosbøl EL; Peterson ED; Holm E; Gislason GH; Zhang Y; Curtis LH; Køber L; Iwata I; Torp-Pedersen C; Setoguchi S
    J Am Geriatr Soc; 2012 Dec; 60(12):2283-9. PubMed ID: 23176182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic management of Alzheimer disease.
    Downey D
    J Neurosci Nurs; 2008 Feb; 40(1):55-9. PubMed ID: 18330411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Do medicines with aim to anti-Alzheimer favor the arisen of epileptic crisis? Discussion about 3 clinical cases].
    Roy M; Castro-Lionard K; Crawford-Achour E; Desseigne N; Beyens MN; Guy C; Imler D; Cornillon D
    Therapie; 2011; 66(3):291-3. PubMed ID: 23189344
    [No Abstract]   [Full Text] [Related]  

  • 19. Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration.
    Kurz A; Van Baelen B
    Dement Geriatr Cogn Disord; 2004; 18(2):217-26. PubMed ID: 15237280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.
    Isik AT; Bozoglu E; Naharci MI; Kilic S
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):454-9. PubMed ID: 21335298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.